Trine Holt Edwin
- Researcher; MD, PhD
Publications 2021
Comparison of Cerebrospinal Fluid Amyloidogenic Nanoplaques With Core Biomarkers of Alzheimer's Disease
Front. Aging Neurosci., 12, 608628
DOI 10.3389/fnagi.2020.608628
Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer's disease
Transl. Neurodegener., 10 (1), 18
DOI 10.1186/s40035-021-00244-3
Neuropsychiatric symptoms and comorbidity: Associations with dementia progression rate in a memory clinic cohort
Int. J. Geriatr. Psychiatr., 36 (6), 960-969
DOI 10.1002/gps.5500
Trajectories and risk factors of dementia progression: a memory clinic cohort followed up to 3 years from diagnosis
Int. Psychogeriatr., 33 (8), PII S1041610220003270-789
DOI 10.1017/S1041610220003270
Evaluation of semi-quantitative measures of F-18-Flutemetamol PET for the clinical diagnosis of Alzheimer's disease
Quant. Imaging Med. Surg.
DOI 10.21037/qims-21-188
Publications 2020
Amyloidogenic Nanoplaques in Cerebrospinal Fluid: Relationship to Amyloid Brain Uptake and Clinical Alzheimer's Disease in a Memory Clinic Cohort
J. Alzheimers Dis., 77 (2), 831-842
DOI 10.3233/JAD-200237
A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer's disease
Alzheimers Dement.-Diagn. Assess. Dis. Monit., 12 (1), e12128
DOI 10.1002/dad2.12128
Time from dementia diagnosis to nursing-home admission and death among persons with dementia: A multistate survival analysis
PLoS One, 15 (12), e0243513
DOI 10.1371/journal.pone.0243513
Publications 2019
Amyloid-beta PET-Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer's disease diagnosis in a memory clinic
PLoS One, 14 (8), e0221365
DOI 10.1371/journal.pone.0221365
The Loss in Expectation of Life due to Early-Onset Mild Cognitive Impairment and Early-Onset Dementia in Norway
Dement. Geriatr. Cogn. Disord., 47 (4-6), 355-365
DOI 10.1159/000501269
Publications 2018
Survival and years of life lost in various aetiologies of dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD) in Norway
PLoS One, 13 (9), e0204436
DOI 10.1371/journal.pone.0204436